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Pathophysiologic Process: Case Study
 The timely administration of 
epinephrine is essential to the effective 
treatment of anaphylaxis, and such 
administration is dependent on 
correctly diagnosing anaphylaxis 
(Campbell, Li, Nicklas, & Sadosty, 
2014).
 No absolute contraindication to 
epinephrine use in the setting of 
anaphylaxis (Campbell, Li, Nicklas, & 
Sadosty, 2014).
 Epinephrine auto-injector education is 
essential
 Anaphylaxis can progress rapidly from 
mild manifestations involving one 
organ-system to severe involvement of 
multiple organ-systems (Campbell, Li, 
Nicklas, & Sadosty, 2014).
 Patient’s having been treated for 
anaphylaxis whom are not candidates 
for hospital admission must be 
monitored in the emergency 
department for at least several hours 
given the risk for a biphasic reaction, 
marked by reoccurrence of 
anaphylaxis symptoms after an initial 
remission (Grossman, Baumann, 
Garcia Peña, Linares, Greenberg, & 
Hernandez-Trujillo, 2013).
 Education on patient specific 
anaphylactic associated triggers is 
essential
 Anaphylaxis is associated with 
significant morbidity and can be fatal 
(Nowak, Farrar, Brenner, Lewis, 
Silverman, Emerman, & Wood, 2013).
 A patient can be experiencing an 
anaphylactic reaction without shock 
(Nowak, Farrar, Brenner, Lewis, 
Silverman, Emerman, & Wood, 2013).
 Anaphylaxis is a long term diagnosis, 
that does not end with discharge from 
the emergency department (Nowak, 
Farrar, Brenner, Lewis, Silverman, 
Emerman, & Wood, 2013).
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Immunology, 133461-467. doi:10.1016/j.jaci.2013.08.016 Food allergy is the most common trigger of anaphylaxis 
in children and adolescents, however other triggers 
include, but are not limited to drug allergies, chemicals, 
insect venom, and exercise. (Gupta, 2014).
 Most patients make at least one mistake in administration 
of autoinjectors; furthermore, most patients make 
multiple mistakes and will not benefit from self-
administration of the potentially life-saving treatment if 
the need arises (Bonds, Asawa, & Ghazi, 2015).
 A large percentage of patients use epinephrine injectors 
incorrectly; therefore, it is essential that healthcare 
providers demonstrate for patients the proper use of an 
epinephrine autoinjector and confirm patient proficiency 
(Campbell, Li, Nicklas, & Sadosty, 2014).
A 31-year-old anxious appearing woman presents to the emergency department 
triage desk. The patient states that she thinks she is having an allergic reaction. She 
further states that she is aware of an existing peanut allergy that was described to her 
in childhood by a parent. The patient states that she is very cautious to not ingest any 
peanut containing products, so she has never experienced any allergy symptoms that 
have required medical attention. The patient has visible urticarial on her arms and 
exposed neck-line, which she states “itches”. The patient states that she feels a 
tightness in her chest, and a sensation of nausea; however, she has not “thrown-up”. 
Initial vitals are as follows: respirations of 20, Lung sounds are clear but diminished 
in the bilateral bases, blood pressure 85/50, oral temperature 37.6 C, heart rate of 
100 with a thready radial pulse, pulse ox saturation of 93% on room air, pupils are 
equal, round, and reactive to light at 3 mm., oral mucosa appears dry with mild to 
moderate edema. She states her last menstrual period was approximately 4 weeks 
ago, has not experienced any changes in her bowel or bladder habits, has not been 
otherwise sick. The patient denies illicit drug and/or tobacco use, and drinks 1-2 
alcoholic drinks per week. Lastly, the patient describes the only other change in her 
daily habits is that yesterday she started a “very-strenuous” physical training regimen 
for an upcoming athletic event, that she wishes to participate in. 
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Underlying Pathophysiology
 A systemic, immediate, hypersensitivity reaction produced by 
immunoglobulin E (IgE-mediated) immunologic release of 
mediators from mast cells and basophils (Lieberman, 2013).
 Type 1 hypersensitivity reactions usually have an early and a 
late phase. The early phase is generated by mast cell and 
basophil mediators that also initiate the later phase events 
(Casey, 2013).
 Most cases of anaphylaxis are immunoglobulin E (IgE)–
mediated. Antibodies exposed to a particular allergen attach to 
mast cells and basophils, resulting in their activation and 
degranulation (Arnold, & Williams, 2011).
 A variety of chemical mediators are released including 
histamine, heparin, tryptase, kallikrein, platelet-activating factor, 
bradykinin, tumor necrosis factor, nitrous oxide, and several 
types of interleukin (Arnold, & Williams, 2011).
Significance of Pathophysiology
 Histamine is the main component of granules and, once released, acts mainly via H1 receptors to trigger vasodilation and 
increased vascular permeability (Casey, 2013).
 H1 receptor activation also causes smooth muscle contraction in the airways, leading to bronchospasm, and in the GI 
tract causing nausea, vomiting, bloating abdominal cramps and diarrhea (Casey, 2013).
 Vasodilation of skin vessels may induce urticaria (Casey, 2013).
 Vasodilation in the soft tissues in the throat and upper airways (angioedema) (Casey, 2013).
 Histamine stimulation of H1 receptors in local nerve endings causes pruritus and sometimes pain (Casey, 2013).
 Prostaglandins and leukotrienes are even more potent vasodilators and broncho-constrictors than histamine. The 
combined vasodilator effects may be sufficient for loss of up to 35 per cent of circulating volume within 10 minutes 
(Casey, 2013).
 Leukotrienes act as signals to recruit late-phase cells (potential cause for biphasic reaction) (Casey, 2013).
 Late-phase responses are due to recruitment of other cells, especially eosinophils, neutrophils and lymphocytes; which 
produce cytokines that promote further inflammation and also damage surrounding tissue (Casey, 2013).
 Epinephrine is a sympathomimetic – it activates the sympathetic nervous system (Casey, 2013).
 Actions of Epinephrine 
 Alpha-1 receptor binding causes systemic vasoconstriction, countering the effects of histamine 
and preventing or relieving hypotension, loss of circulating volume, and angioedema that might 
obstruct the airways (Casey, 2013).
 Beta-1 adrenergic receptor binding increases heart rate and cardiac output to help manage 
shock (Casey, 2013).
 Beta-2 binding causes bronchodilation and also reduces the release of histamine from mast cells 
(Casey, 2013).
SYMPTOMS
For Any of the Following Symptoms
(Stay with individual. Never leave alone.)
One or more of the following:
LUNG: Short of breath, wheezing, repetitive coughing
HEART: Pale, blue, faint, weak pulse, dizzy, confused
THROAT: Tight, hoarse, trouble breathing and/or 
swallowing/speaking
MOUTH: Significant swelling of the tongue and/or lips
SKIN: Many hives over body, widespread redness
GUT: Repetitive vomiting, severe diarrhea
NEURO: Felling something bad is about to happen, anxiety, fear
https://www.odh.ohio.gov/odhprograms/chss/schnurs/guidepub.aspx
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Symptoms
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Engaging Patients in Their Own Preparedness and Therapy
 Action Plans:
 Provide an anaphylaxis plan of action that is illustrative 
and written in an understandable form
 Provide the plan of action to patients, parents, caretakers, 
and schools
 Evaluate the content of the written plan of action and 
determine the understandability
 Ensure that patients, parents, caretakers, and schools understand:
 The significance of risk
 The possibility of increasing severity with subsequent 
exposure
 Relevant avoidance measures
 Early recognition of symptoms
 Appropriate treatment with Epinephrine, or an 
Epinephrine autoinjector
 Improve adherence through tailored self-management plans, one-on-
one counseling sessions, or telephone follow-up. Follow-up 
discussions after a visit should include the following questions:
 Did you pick up your medicine?
 Do you have any questions about what we discussed 
regarding how to use the medicine and why you need it?
 Did you have any managed care insurance problems?
Bennett, Fromer, & Hayden, 2014
Anaphylaxis is an emergent, life-threatening condition and quick 
provider response is imperative. Symptoms of anaphylaxis may include, but are not 
limited to, difficulty in breathing, an abrupt fall in blood pressure, edema, hives, 
itching, and gastrointestinal cramping (McCance, & Heuther, 2014, p.1675). A study 
published in the Journal of Allergy and Clinical Immunology (JACI) indicates the 
prevalence of anaphylaxis in the general population is at least 1.6%, and possibly 
affecting as many as 1 in 20 in specific populations (Wood, Camargo, Lieberman, 
Sampson, Schwartz, Zitt, & Simons, 2014). When a patient has an acute and sever 
anaphylactic response, that patient’s healthcare provider must be ready to 
immediately act using an expert level of awareness, and evidence based-knowledge. 
This paper is intended to cultivate a spirit of inquiry into, and a better understanding 
of anaphylaxis. Every provider must be able to recognize anaphylaxis; but, exceptional 
providers will recognize anaphylactic: signs, symptoms, underlying pathophysiology, 
significance of the pathophysiology, significance of the required nursing care, and 
implications for future management of the disease process. 
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